⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12950636 | 1.00 | — | — | |
| SCHEMBL24221995 | 0.85 | — | — | |
| SCHEMBL21533368 | 0.81 | LGALS8 (0.32) | — | |
| SCHEMBL19940051 | 0.79 | — | — | |
| SCHEMBL13447823 | 0.78 | LGALS8 (0.35) | — | |
| SCHEMBL12292298 | 0.77 | LGALS8 (0.33) | — | |
| SCHEMBL19631498 | 0.76 | LGALS8 (0.33) | — | |
| SCHEMBL14987856 | 0.76 | — | — | |
| SCHEMBL18390208 | 0.73 | LGALS8 (0.30) | — | |
| SCHEMBL16729887 | 0.73 | LGALS8 (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11033571-B2 | Pharmaceutical composition for preventing or treating hepatitis B | AM SCIENCES INC (KR) | 2021-06-15 | — | — | US | disclosed |
| US-20190343864-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING HEPATITIS B | AM SCIENCES INC (KR) | 2019-11-14 | — | — | US | disclosed |